Plasma lipid profile, lipid peroxidation and antioxidant status in preeclamptic and uncomplicated pregnancies in Bangladesh

Journal of Medical Sciences

Volumn 7, Issue 8, 2007, Pages 1276-1282

  Howlader, Zakir H ^a   Kabir, Yearul ^b   Khan, Tanzir A ^c   Islam, Rakibul ^a   Begum, Firoza ^d   Huffman, Fatma G ^e  

^a UNIVERSITY OF DHAKA   (Bangladesh)

^b KUWAIT UNIVERSITY   (Kuwait)

^c Bangladesh Council of Scientific and Industrial Research   (Bangladesh)

^d BANGABANDHU SHEIKH MUJIB MEDICAL UNIVERSITY   (Bangladesh)

^e FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

Lipid hydroperoxides; Lipid profile; Preeclampsia; Thiobarbituric acid reactive substances; Total antioxidant status

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPID HYDROPEROXIDE; LIPID PEROXIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BANGLADESH; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPID PEROXIDATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PREECLAMPSIA; PREGNANCY; STANDARD; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 37349013908     PISSN: 16824474     EISSN: 18125727     Source Type: Journal    
DOI: 10.3923/jms.2007.1276.1282     Document Type: Article

References (46)

1. Atamer, Y., Y. Kocyigit, B. Yokus, A. Atamer and A.C. Erden, 2005. Lipid peroxidation, antioxidant defense, status of trace metals and leptin levels in preeclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol., 1: 60-66.
2. Aydin, S., A. Benian, R. Madazli, S. Uludag, H. Uzun and S. Kaya, 2004. Plasma malondialdehyde, superoxide dismutase, sE-selectin, fibronectin, enthothelin-1 and nitric oxide levels in women with preeclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol., 113: 21-25.
3. Barden, A., D. Graham and L.J. Beilin et al., 1997. Neutrophil CD 11B expression and neutrophil activation in pre-eclampsia. Clin. Sci. (London), 92: 37-44.
4. Belo, L., M. Caslake and D. Gaffney et al., 2002. Changes in LDL size and HDL concentration in normal and preeclamptic pregnancies. Atherosclerosis, 162: 425-432.
5. Cekmen, M.B., A.B. Erbagci and A. Balat et al., 2003. Plasma lipid and lipoprotein concentrations in pregnancy induced hypertension. Clin. Biochem., 36: 575-548.
6. Chappell, L.C., P.T. Seed and A.L. Briley et al., 1999. Effect of antioxidants on the occurrence of preeclampsia in women at increased risk: A randomized trial. Lancet, 54: 810-816.
7. Chappell, L.C., P.T. Seed and F.J. Kelly et al., 2002. Vitamin C and E supplementation in women at risk of preeclampsia is associated with changes in indices of oxidative stress and placental function. Am. J. Obstet. Gynecol., 187: 777-784.
8. Crocker, I.P., R.P. Wellings, J. Fletcher and P.N. Baker, 1999. Neutrophil function in women with preeclampsia. Br. J. Obstet. Gynecol., 106: 822-828.
9. Diedrich, F., A. Renner, W. Rath, W. Kuhn and E. Wieland, 2001. Lipid hydroperoxides and free radical scavenging enzyme activities in preeclampsia and HELLP (hemolysis, elevated liver enzymes and low platelet count) syndrome: No evidence for circulating primary products of lipid peroxidation. Am. J. Obstet. Gynecol., 185: 166-172.
10. Fauveau, V., K.A Konij, J. Chakrabarty and A.L. Chowdhury, 1988. Causes of maternal mortality in Rural Bangladesh. Bull. WHO, 66: 643-651.
11. Friedewald, W.T., R.I. Levy and D.S. Fredrickson, 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem., 18: 499-502.
12. Gratacos, E., E. Casals, R. Deulofeu, V. Cararach, P.L. Alonso and A. Fortuny, 1998. Lipid peroxide and vitamin E patterns in women with different types of hypertension in pregnancy. Am. J. Obstet. Gynecol., 178: 1072-1076.
13. Gratacos, E., 2000. Lipid-mediated endothelial dysfunction: A common factor to preeclampsia and chronic vascular disease. Eur. J. Obstet. Gynecol. Reprod. Biol., 92: 63-66.
14. Hennessy, A., H.L. Pilmore, L.A. Simmons and D.M. Painter, 1999. A deficiency of placental IL-10 in preeclampsia. J. Immunol., 163: 3491-3495.
15. Heyl, W., S. Handt and F. Reister et al., 1999. Elevated soluble adhesion molecules in women with pre-eclampsia. Do cytokines like tumour necrosis factor-alpha and nterleukin-1 beta cause endothelial activation. Eur. J. Obstet. Gynecol. Reprod. Biol., 86: 35-41.
16. Hubel, C.A., M.K. McLaughlin, R.W. Evans, B.A. Hauth, C.J. Sims and J.M. Roberts, 1996. Fasting serum triglycerides, free fatty acids and malondialdehyde are increased in preeclampsia, are positively correlated and decrease within 48 h post partum. Am. J. Obstet. Gynecol., 174: 975-982.
17. Hubel, C.A., 1999. Oxidative stress in the pathogenesis of preeclampsia. Proc. Soc. Exp. Biol. Med., 222: 222-235.
18. Kaaja, R., M.J. Tikkanen, L. Viinikka and O. Ylikorkala, 1995. Serum lipoproteins, insulin and urinary prostanoid metabolites in normal and hypertensive pregnant women. Obstet. Gynecol., 85: 353-356.
19. Kupferminc, M.J., A.M. Peaceman, S. Dollberg and M.L. Socol, 1999. Tumor necrosis factor-alpha is decreased in the umbilical cord plasma of patients with severe preeclampsia. Am. J. Perinatol., 16: 203-208.
20. Llurba, E., E. Gratacos, P. Martin-Gallan, L. Cabero and C. Dominguez, 2004. A comprehensive study of oxidative stress and antioxidant status in preeclampsia and normal pregnancy. Free. Radic. Biol. Med., 37: 557-570.
21. Lorentzen, B. and T. Henriksen, 1998. Plasma lipids and vascular dysfunction in preeclampsia. Semin. Reprod. Endocrinol., 16: 33-39.
22. Madazli, R., A. Benian, K. Gumustas, H. Uzun and V. Ocak, 1999. Lipid peroxidation and antioxidants in preeclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol., 85: 205-208.
23. Miller, N.J., C. Rice-Evans, M.J. Davies and G.V. Milner, 1993. A novel method for measuring antioxidant capacity and its application to monitoring antioxidant status in premature neonates. Clin. Sci., 84: 407-412.
24. Morri, J.M., N.K. Gopaul and M.J. Endresen et al., 1998. Circulating markers of oxidative stress are raised in normal pregnancy and preeclampsia. Br. J. Obstet. Gynecol., 105: 1195-1199.
25. Mutlu-Turkoglu, U., E. Ademoglu, L. Ibrahimoglu, G. Aykac-Toker and M. Uysal, 1998. Imbalance between lipid peroxidation and antioxidant status in preeclampsia. Gynecol. Obstet. Invest., 46: 37-40.
26. Myatt, L. and M. Miodovnik, 1999. Prediction of preeclampsia. Semin. Perinatol., 23: 45-57.
27. Nourooz-Zadeh, J., J. Tajaddini-Sarmadi and S.P. Wolff, 1994. Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphine. Anal. Biochem., 220: 403-409.
28. Ogura, K., T. Miyatake, O. Fukui, T. Kakamura, T. Kameda and G. Yoshino, 2002. Low-density lipoprotein particle diameter in normal pregnancy and preeclampsia. J. Atheroscler. Thromb., 9: 42-47.
29. Poston, L., A.L. Briley, P.T. Seed, F.J. Kelly and A.H. Sherman, 2006. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): Randomized placebo-controlled trial. Lancet, 367: 145-1154.
30. Redman, C.W. and I.L. Sargent, 2005. Latest advances in understanding preeclampsia. Science, 308: 1592-1594.
31. Regan, C.L., R.J. Levin and D.D. Baird et al., 2001. No evidence of lipid peroxidation in severe preeclampsia. Am. J. Obstet. Gynecol., 185: 572-578.
32. Rinehart, B.K., D.A. Terrone and S. Lagoo-Deenadayalan et al., 1999. Expression of the placental cytokine tumor necrosis factor alpha, interleukin 1 beta and interleukin 10 is increased in preeclampsia. Am. J. Obstet. Gynecol., 181: 915-920.
33. Roberts, J.M. and K.Y. Lain, 2002. Recent insights into the pathogenesis of preeclampsia. Placenta, 23: 359-372.
34. Roberts, J.M. and H.S. Gammill, 2005. Preeclampsia: Recent Insights. Hypertension, 46: 1243-1249.
35. Rosing, U., G. Samsioe, A. Olund, B. Johansson and A. Kallner, 1989. Serum levels of apolipoprotein A-I, A-II and HDL-cholesterol in second half of normal pregnancy and in pregnancy complicated by preeclampsia. Horm. Metab. Res., 21: 376-382.
36. Sagol, S., E. Ozkinay, S. Ozsener, L. Ibrahimoglu, G. Aykac-Toker and M. Uysal, 1998. Imbalance between lipid peroxidation and antioxidant status in preeclampsia. Gynecol. Obstet. Invest., 46: 37-40.
37. Saito, S., H. Umekage and Y. Sakamoto et al., 1999. Increased T-helper-1-type immunity and decreased T-helper-2-type immunity in patients with preeclampsia. Am. J. Reprod. Immunol., 41: 297-306.
38. Sattar, N., A. Gaw, C.J. Packard and I.A. Greer, 1996. Potential pathogenic roles of aberrant lipoprotein and fatty acid metabolism in preeclampsia. Br. J. Obstet. Gynecol., 103: 614-620.
39. Sattar, N., I.A. Greer and J. Louden et al., 1997. Lipoprotein subfraction changes in normal pregnancy: Threshold effect of plasma triglyceride on appearance of small, dense low density lipoprotein. J. Clin. Endocrinol. Metab., 82: 2483-2491.
40. Shaarawy, M., A. Aref, M.E. Salem and M. Sheiba, 1998. Radical-scavenging antioxidants in preclampsia and eclampsia. Int. J. Gynecol. Obstet., 60: 123-128.
41. Tsukimori, K., H. Maeda and K. Ishida et al., 1993. The superoxide generation of neutrophils in normal and preeclamptic pregnancies. Obstet. Gynecol., 81: 536-540.
42. Uotila, J.T., R.J. Tuimala and T.M. Aarnio, 1993. Findings on lipid peroxidation and antioxidant function in hypertensive complications of pregnancy. Br. J. Obstet. Gynecol., 100: 270-276.
43. Wakatsuki, A., N. Ikenoue, Y. Okatani, K. Shinohara and T. Fukaya, 2000. Lipoprotein particles in preeclampsia: Susceptibility to oxidative modification. Obstet. Gynecol., 96: 55-59.
44. Wang, Y. and S.W. Walsh, 1996. Antioxidant activities and mRNA expression of superoxide dismutase, catalase and glutathione peroxidase in normal and preeclamptic placentas. J. Soc. Gynecol. Invest., 3: 179-184.
45. WHO, 2005. Make every mother and child count. World Health Report, WHO, Geneva.
46. Yagi, K., 1998. Simple procedure for specific assay of lipid hydroperoxides in serum or plasma. Free. Radic. Antioxidant. Protocol., 108: 101-106.